-
Ratko Mladic was one of the most notorious figures of a war that killed over 100,000 people in the 1990s. He commanded his troops to "scorch the brains" of the Bosnian Muslims and boasted of being a "Serbian God."
-
NPR critics remember some of their favorite Dolly performances — including a duet with Kermit the Frog and the twinkle in Dolly's eye singing with Linda Ronstadt and Emmylou Harris.
-
There's a fear that people facing international extradition granted bail could flee. Andrew Tate and his brother face a total of 59 criminal charges in the U.K., including rape and human trafficking.
-
Nondisclosure agreements covered up negotiations between a tech company and several local and state officials, surprising local residents. It's a tactic used around the country in data center deals.
-
A push by President Trump could mean the elimination of a safety standard designed to keep radiation exposure as low as possible.
-
Ossoff should be among the most vulnerable Senate incumbents this year. Instead, the Georgia Democrat has opened a steady lead in polls and is increasingly seen as a potential 2028 contender.
-
A lawsuit seeks to block President Trump's name from going back on the center. The center's board warns that if renovation plans don't go forward, it may be demolished.
-
2026 has already brought a wave of setbacks for social media giants as pressure grows on Big Tech from regulators and lawmakers around the world.
-
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
-
The official in charge of President Trump's ceasefire plan for Gaza criticized Israel for its attacks on the Palestinian territory and warned that the alternative to the U.S. proposal is the next war.
-
The Japanese artist has died at age 97. Kusama's polka dotted pumpkins, "Infinity Rooms," and other repetitive and dreamlike artworks have been shown in museums and galleries worldwide.
-
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.